ABBV

NYSE · Biotechnology

Abbvie Inc

S&P 500 Mega-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield

$291.31

+3.07 (+1.07%)

As of Nov 7, 1:00 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 32 82%

Hold 7 18%

Sell 0 0%

Price Target

Analyst Price Target -11.6% upside

Low Target $173.19

Average Target $257.58

High Target $337.66

Current Price $291.31

Current
$291.31

Target
$257.58

$173.19 $257.58 avg $337.66

Scenario Analysis

Bear Case

$173.19

-40.5%

Low target

Base Case

$257.58

-11.6%

Avg target

Bull Case

$337.66

+15.9%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$302.93

-3.8% from high

52-Week Low

$190.75

+52.7% from low

50-Day SMA

$271.95

+7.1% vs SMA

200-Day SMA

$238.94

+21.9% vs SMA

RSI (14)

58.7

Neutral

Target vs 52W High

$257.58

-15.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%